The Thursday morning news reports: January 8, 2009

Posted on January 8, 2009 by Sitemaster

This morning’s news reports address: Prostate cancer risk and obesity (again) Italian experience with HIFU at a median follow-up of about 2 years The prognostic value of a 5-year PSA value <0.2 ng/ml in men treated with brachytherapy (with or without EBRT and/or hormones) Proposed European guidelines on the need to remove the seminal vesicles [...]

Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: , , , , , , , , | Leave a Comment »

The vitamins in cancer “bust”

Posted on January 7, 2009 by Sitemaster

Many readers of this blog may want to make sure they read the article published this morning in USA Today entitled, “Vitamins get an ‘F’ in cancer.”

Filed under: Management, Prevention, Treatment | Tagged: | Comments Off

The Wednesday news reports: January 7, 2009

Posted on January 7, 2009 by Sitemaster

Wednesday’s news reports include  items on: The occurrence of “clinically insignificant” prostate cancer in an autopsy series The value of a patient decision aid in management of localized prostate cancer The clinical value of the 2005 International Society of Urologic Pathology Gleason Grading Consensus score (ISUP GS)  Outcomes of radical prostatectomy for prostate cancer discovered [...]

Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: , , , , , | Leave a Comment »

Prostate cancer in Jamaica: a 6-year review

Posted on January 7, 2009 by Sitemaster

It is generally believed that prostate cancer in Jamaica is of very high incidence, that it is often diagnosed when patients are older, and that patients tend to have high PSA levels at diagnosis, suggesting more advanced disease.

Filed under: Diagnosis, Risk | Tagged: , , | Leave a Comment »

“A Private Song …”

Posted on January 6, 2009 by Sitemaster

Dana Jennings’ latest musings on his prostate cancer can be found on the New York Times Health section today. … And in another New York Times article, Denise Grady writes about the interesting ethical question of whether doctors should tell patients that they might (or will?) get better care for their disease at a different [...]

Filed under: Living with Prostate Cancer | Tagged: | Leave a Comment »

All the early Tuesday news: January 6, 2009

Posted on January 6, 2009 by Sitemaster

There are multiple news reports available today, including coverage of the following: Vegetable consumption and prostate cancer risk Anti-hypertensive medications and prostate cancer risk Prostate cancer incidence among South Indian and Pakistani immigrants to the United States Bladder neck contracture and type of surgery Cytotoxic and targeted chemotherapies in the managment of prostate cancer The [...]

Filed under: Diagnosis, Living with Prostate Cancer, Management, Prevention, Risk, Treatment | Tagged: , , , , , , , , , , , , , | Leave a Comment »

Manny “feels like a man again”

Posted on January 5, 2009 by Sitemaster

Today’s Boston Globe carries a story about Manny Hamelburg, a long-time prostate cancer patient and activist who finally got fed up with “zero libido for seven years.” So Manny started taking testosterone.

Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: , | Leave a Comment »

The Monday evening news: January 5, 2008

Posted on January 5, 2009 by Sitemaster

In brief news today there is more on Fosamax (this time being associated with a risk for esophageal cancer) and on CureVac’s early stage trial of CV9103.

Filed under: Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: , , , | Leave a Comment »

Furore about Fosamax

Posted on January 5, 2009 by Sitemaster

There has been a lot of media noise in the past few days about two studies suggesting that a drug called alendronate (Fosamax/Merck) may be associated with a significant risk for osteonecrosis of the jaw (ONJ).

Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: , , , , | Leave a Comment »

The weekend news reports: January 3, 2008

Posted on January 3, 2009 by Sitemaster

There are three new reports today, each of which seemed sufficiently important to merit its own individual commentary: PSA kinetics and prediction of outcomes of untreated patients Exercise and radiotherapy: a controlled, randomized trial and The psychosocial aspects to prostate cancer screening

Filed under: Uncategorized | Comments Off

The psychosocial aspects to prostate cancer screening

Posted on January 3, 2009 by Sitemaster

It is becoming clearer what psychosocial factors motivate or discourage men from taking advantage of PSA testing and physical examination (DREs) as screening tests for prostate cancer. Data from a large study of this issue have now been published.

Filed under: Diagnosis, Risk | Tagged: , , , | Leave a Comment »

Exercise and radiotherapy: a controlled, randomized trial

Posted on January 3, 2009 by Sitemaster

It has long been known that external beam radiotherapy for treatment of prostate cancer may cause unfavorable changes in fatigue, quality of life (QOL), and physical fitness. This commentary discusses the results from the Prostate Cancer Radiotherapy and Exercise Versus Normal Treatment study, conducted in Canada.

Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: , , | Leave a Comment »

PSA kinetics and prediction of outcomes of untreated patients

Posted on January 3, 2009 by Sitemaster

There has been an on-going difference of opinion within sections of the urology community regarding the value of PSA velocity and/or PSA doubling times in predicting outcomes to first-line prostate cancer treatment.

Filed under: Diagnosis, Management, Risk | Tagged: , , | Leave a Comment »

ASCO highlights three advances in prostate cancer in 2008

Posted on January 2, 2009 by Sitemaster

Each year the American Society for Clinical Oncology (ASCO) highlights the major advances made in the prevention and management of cancer (click here for the full text). Three advances made the list for prostate cancer in 2008 … but almost no one is acting on one of the most important of these!

Filed under: Drugs in development, Prevention | Tagged: , | 3 Comments »

The Friday news reports: January 2, 2009

Posted on January 2, 2009 by Sitemaster

Today’s news report contains items on: The estimation of localized prostate cancer tumor size based on PSA data alone Mitochondrial genes and prostate cancer risk Results of a Phase II trial of strontium-89 with chemohormonal therapy in men with metastatic bone disease The association between spirituality and quality of life in low-income patients with metastatic disease [...]

Filed under: Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: , , , , , , | Leave a Comment »

« Previous Page — Next Page »
Follow

Get every new post delivered to your Inbox.

Join 249 other followers